English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 17 July 2012, 17:45 HKT/SGT
Share:
    

Source: A*STAR
A*STAR Chief Scientist Wins Cancer Research UK Lifetime Achievement Prize

SINGAPORE, July 17, 2012 - (ACN Newswire) - A*STAR Chief Scientist, Professor Sir David Lane is the recipient of this year's Cancer Research UK Lifetime Achievement Award. The award recognises his contribution to the pioneering research that led to the discovery of the p53, often called the 'guardian of the genome'.

The p53 protein, which is mutated in more than 50 per cent of cancers, was first discovered in 1979 and since then Professor Lane has dedicated his career to understanding how it protects against cancer. This discovery revolutionised scientists' understanding of how cells grow and divide and opened a new window on cancer. His recent work has focused on controlling p53 and this has identified several promising targets for developing new cancer drugs.

Professor Lane's work has been supported for more than 30 years by Cancer Research UK and he served as the charity's first chief scientist between 2007 and 2010. Professor Lane was knighted for his services to cancer research in 2000.

Professor Sir David Lane, who now runs the p53 Lab under A*STAR, said: "I'm delighted to receive this award, which would not have been possible without the support of my colleagues and Cancer Research UK. Decades on from our discovery of p53, we are still making incredible discoveries about how it behaves and controls cells and we're now turning this knowledge into new treatments for cancer. It is an exciting time to be in the field of p53 research and we continue to tackle the more challenging aspects of p53 research here at A*STAR."

Mr Lim Chuan Poh, Chairman A*STAR, said, "David's work has been critical to our understanding of cancer and will continue to have a profound impact on the development of cancer treatments for years to come. He has also been tireless in his efforts to continually forge meaningful international collaborations and develop impactful public-private partnerships. Most heartening is his efforts at mentoring the next generation of young scientists at A*STAR today to push the boundaries of discoveries and innovation. He is truly deserving of this honour and I offer him my heartiest congratulations."

The Lifetime Achievement in Cancer Research Prize is awarded by Cancer Research UK each year to honour the achievements of scientists and clinicians in the cancer research community. The prize recognises individuals who have produced exceptional research throughout their career, specifically contributing towards furthering the understanding of cancer.

Professor Lane will be presented with the award at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool on Sunday 4 November, where he will also give a plenary lecture.

Contact:
Ong Siok Ming
Corporate Communications
Agency for Science, Technology and Research
Tel: +65 6826 6254
Email: ong_siok_ming@a-star.edu.sg


Topic: Research and development
Source: A*STAR

Sectors: Science & Research
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

A*STAR Related News
Dec 6, 2022 14:00 HKT/SGT
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
June 2, 2022 21:00 HKT/SGT
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
June 2, 2022 21:00 HKT/SGT
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Sept 30, 2021 16:00 HKT/SGT
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes
July 31, 2020 08:00 HKT/SGT
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575